A two-stage design with two co-primary endpoints

Por Song, James X.
Publicado no Contemp Clin Trials Commun (2015)

Detection of Herpes Simplex Virus Type 2-Specific Immunoglobulin G Antibodies in African Sera by Using Recombinant gG2, Western Blotting, and gG2 Inhibition

Por Hogrefe, Wayne, Su, Xin, Song, James, Ashley, Rhoda, Kong, Lilly
Publicado em 2002

DHHC20 Palmitoyl-Transferase Reshapes the Membrane to Foster Catalysis

Por Stix, Robyn, Song, James, Banerjee, Anirban, Faraldo-Gómez, José D.
Publicado no Biophys J (2020)

Randomized Controlled Trial of Moxifloxacin Compared With Piperacillin–Tazobactam and Amoxicillin–Clavulanate for the Treatment of Complicated Intra-abdominal Infections

Por Malangoni, Mark A., Song, James, Herrington, Janet, Choudhri, Shurjeel, Pertel, Peter
Publicado em 2006

Chemoenzymatic Reversible Immobilization and Labeling of Proteins without Prior Purification

Por Rashidian, Mohammad, Song, James M., Pricer, Rachel E., Distefano, Mark D.
Publicado em 2012

Chromatin State-Based Analysis of Epigenetic H3K4me3 Marks of Arabidopsis in Response to Dark Stress

Por Yan, Hengyu, Liu, Yue, Zhang, Kang, Song, James, Xu, Wenying, Su, Zhen
Publicado no Front Genet (2019)

An optimized negative-staining protocol of electron microscopy for apoE4•POPC lipoprotein

Por Zhang, Lei, Song, James, Newhouse, Yvonne, Zhang, Shengli, Weisgraber, Karl H., Ren, Gang
Publicado em 2010

High-Throughput Chemical Probing of Full-Length Protein–Protein Interactions

Por Song, James M., Menon, Arya, Mitchell, Dylan C., Johnson, Oleta T., Garner, Amanda L.
Publicado no ACS Comb Sci (2017)

The role of olefin geometry in the activity of hydrocarbon stapled peptides targeting eukaryotic translation initiation factor 4E (eIF4E)

Por Song, James M., Gallagher, Erin E., Menon, Arya, Mishra, Lauren D., Garner, Amanda L.
Publicado no Org Biomol Chem (2019)

Hydrogen Peroxide-Generating Electrochemical Scaffold Activity against Trispecies Biofilms

Por Raval, Yash S., Mohamed, Abdelrhman, Song, James, Greenwood-Quaintance, Kerryl E., Beyenal, Haluk, Patel, Robin
Publicado no Antimicrob Agents Chemother (2020)

Rodent Estrous Cycle Response to Incomplete Spinal Cord Injury, Surgical Interventions, and Locomotor Training

Por Shah, Prithvi K., Song, James, Kim, Samuel, Zhong, Hui, Roy, Roland R., Edgerton, V. Reggie
Publicado em 2011

Consideration of Binding Kinetics in the Design of Stapled Peptide Mimics of the Disordered Proteins Eukaryotic Translation Initiation Factor 4E-Binding Protein 1 and Eukaryotic Tr...

Por Gallagher, Erin E., Song, James M., Menon, Arya, Mishra, Lauren D., Chmiel, Alyah F., Garner, Amanda L.
Publicado no J Med Chem (2019)

Impact of prior anthracycline or taxane use on eribulin effectiveness as first-line treatment for metastatic breast cancer: results from two phase 2, multicenter, single-arm studie...

Por O’Shaughnessy, Joyce, McIntyre, Kristi, Schwartzberg, Lee, Wilks, Sharon, Puhalla, Shannon, Berrak, Erhan, Song, James, Vahdat, Linda
Publicado no Springerplus (2015)

Clinical effects of prior trastuzumab on combination eribulin mesylate plus trastuzumab as first-line treatment for human epidermal growth factor receptor 2 positive locally recurr...

Por Puhalla, Shannon, Wilks, Sharon, Brufsky, Adam M, O’Shaughnessy, Joyce, Schwartzberg, Lee S, Berrak, Erhan, Song, James, Vahdat, Linda
Publicado no Breast Cancer (Dove Med Press) (2016)

The Src Homology 2 Domain of Vav Is Required for Its Compartmentation to the Plasma Membrane and Activation of C-Jun Nh(2)-Terminal Kinase 1

Por Arudchandran, Ramachandran, Brown, Martin J., Peirce, Matthew J., Song, James S., Zhang, Juan, Siraganian, Reuben P., Blank, Ulrich, Rivera, Juan
Publicado em 2000

Phase 2 study of eribulin mesylate as first-line therapy for locally recurrent or metastatic human epidermal growth factor receptor 2-negative breast cancer

Por McIntyre, Kristi, O’Shaughnessy, Joyce, Schwartzberg, Lee, Glück, Stefan, Berrak, Erhan, Song, James X., Cox, David, Vahdat, Linda T.
Publicado em 2014

Erratum to: Phase 2 study of eribulin mesylate as first-line therapy for locally recurrent or metastatic human epidermal growth factor receptor 2-negative breast cancer

Por McIntyre, Kristi, O’Shaughnessy, Joyce, Schwartzberg, Lee, Glück, Stefan, Berrak, Erhan, Song, James X., Cox, David, Vahdat, Linda T.
Publicado no Breast Cancer Res Treat (2014)

Subgroup Analyses from a Phase 3, Open-Label, Randomized Study of Eribulin Mesylate Versus Capecitabine in Pretreated Patients with Advanced or Metastatic Breast Cancer

Por Twelves, Chris, Awada, Ahmad, Cortes, Javier, Yelle, Louise, Velikova, Galina, Olivo, Martin S., Song, James, Dutcus, Corina E., Kaufman, Peter A.
Publicado no Breast Cancer (Auckl) (2016)

“New” metastases are associated with a poorer prognosis than growth of pre-existing metastases in patients with metastatic breast cancer treated with chemotherapy

Por Twelves, Christopher, Cortes, Javier, Kaufman, Peter A., Yelle, Louise, Awada, Ahmad, Binder, Terri A., Olivo, Martin, Song, James, O’Shaughnessy, Joyce A., Jove, Maria, Perez, Edith A.
Publicado no Breast Cancer Res (2015)

Morphology and structure of lipoproteins revealed by an optimized negative-staining protocol of electron microscopy

Por Zhang, Lei, Song, James, Cavigiolio, Giorgio, Ishida, Brian Y., Zhang, Shengli, Kane, John P., Weisgraber, Karl H., Oda, Michael N., Rye, Kerry-Anne, Pownall, Henry J., Ren, Gang
Publicado em 2011